Search

Your search keyword '"CRLCC Val d'Aurelle - Paul Lamarque-Université de Montpellier (UM)-Institut National de la Santé et de la Recherche Médicale (INSERM)"' showing total 327 results

Search Constraints

Start Over You searched for: Author "CRLCC Val d'Aurelle - Paul Lamarque-Université de Montpellier (UM)-Institut National de la Santé et de la Recherche Médicale (INSERM)" Remove constraint Author: "CRLCC Val d'Aurelle - Paul Lamarque-Université de Montpellier (UM)-Institut National de la Santé et de la Recherche Médicale (INSERM)"
327 results on '"CRLCC Val d'Aurelle - Paul Lamarque-Université de Montpellier (UM)-Institut National de la Santé et de la Recherche Médicale (INSERM)"'

Search Results

1. Dihydropyrimidinase protects from DNA replication stress caused by cytotoxic metabolites

2. Isocitrate dehydrogenase 1 mutations prime the all-trans retinoic acid myeloid differentiation pathway in acute myeloid leukemia

3. Targeting the NRG1/HER3 pathway in tumor cells and cancer-associated fibroblasts with an anti-neuregulin 1 antibody inhibits tumor growth in pre-clinical models of pancreatic cancer

4. HER3 as biomarker and therapeutic target in pancreatic cancer: new insights in pertuzumab therapy in preclinical models

5. BAG6/BAT3 modulates autophagy by affecting EP300/p300 intracellular localization

6. Estrogen-related receptor γ is an in vivo receptor of bisphenol A

7. Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA

8. Epidemiological study of prostate cancer (EPICAP): a population-based case-control study in France

9. Circulating Cell-Free DNA from Colorectal Cancer Patients May Reveal High KRAS or BRAF Mutation Load

10. MAPK14/p38α confers irinotecan resistance to TP53-defective cells by inducing survival autophagy

11. [PAIR-gynaecology: multi/interdisciplinary for gynecologic cancer research. Problems needed to be resolved]

12. New Topoisomerase I mutations are associated with resistance to camptothecin

13. Targeting the p38 MAPK Pathway Inhibits Irinotecan Resistance in Colon Adenocarcinoma

14. Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers

15. [Cancer genetics: estimation of the needs of the population in France for the next ten years]

16. The exonuclease ISG20 mainly localizes in the nucleolus and the Cajal (Coiled) bodies and is associated with nuclear SMN protein-containing complexes

17. Diagnostic chest X-rays and breast cancer risk among women with a hereditary predisposition to breast cancer unexplained by a BRCA1 or BRCA2 mutation

18. RETRACTED: Recommandations françaises du Comité de Cancérologie de l’AFU — Actualisation 2018—2020 : tumeurs de la voie excrétrice supérieure

19. Real-time shear wave ultrasound elastography: a new tool for the evaluation of diaphragm and limb muscle stiffness in critically ill patients

20. iPSC line derived from a Bloom syndrome patient retains an increased disease-specific sister-chromatid exchange activity

21. Cerpegin-derived furo[3,4-c]pyridine-3,4(1H,5H)-diones enhance cellular response to interferons by de novo pyrimidine biosynthesis inhibition

22. Adverse Drug Events Detected by Clinical Pharmacists in an Emergency Department

23. Involvement of the Anti-Müllerian Hormone and its receptors in gynaecological cancers : therapeutic strategies using associated antibodies

24. The evolution of resistance and tolerance as cancer defences

25. Autocrine Adenosine Regulates Tumor Polyfunctional CD73+CD4+ Effector T Cells Devoid of Immune Checkpoints

26. Ki-67 supports global gene expression programmes driving tumourigenesis 2

27. Transportin-1 binds to the HIV-1 capsid via a nuclear localization signal and triggers uncoating

28. Use of physiological information based on grayscale images to improve mass spectrometry imaging data analysis from biological tissues

29. Synthetic hydrophobic peptides derived from MgtR weaken Salmonella pathogenicity and work with a different mode of action than endogenously produced peptides

30. A Complex Network of Tumor Microenvironment in Human High-Grade Serous Ovarian Cancer

31. Dynamic evaluation of circulating tumour cells in patients with advanced gastric and oesogastric junction adenocarcinoma: Prognostic value and early assessment of therapeutic effects

32. Atomic Force Microscopy Study of the Topography and Nanomechanics of Casein Micelles Captured by an Antibody

33. Molecular subtypes of metastatic colorectal cancer are associated with patient response to irinotecan-based therapies

34. The performance of PI-RADSv2 and quantitative apparent diffusion coefficient for predicting confirmatory prostate biopsy findings in patients considered for active surveillance of prostate cancer

35. Syringaresinol: A Renewable and Safer Alternative to Bisphenol A for Epoxy-Amine Resins

36. Factors Affecting Tamoxifen Metabolism in Patients With Breast Cancer: Preliminary Results of the French PHACS Study

37. Interplay of Protein Disorder in Retinoic Acid Receptor Heterodimer and Its Corepressor Regulates Gene Expression

38. Drugs That Modify Cholesterol Metabolism Alter the p38/JNK-Mediated Targeted and Nontargeted Response to Alpha and Auger Radioimmunotherapy

39. CCSP counterbalances airway epithelial-driven neutrophilic chemotaxis

40. Management of Adolescent Hyperandrogenism: Still a Challenge?

41. Inhibition of Ataxia-Telangiectasia Mutated and RAD3-Related ( ATR ) Overcomes Oxaliplatin Resistance and Promotes Antitumor Immunity in Colorectal Cancer

42. Activity of a Synthetic Peptide Targeting MgtC on Pseudomonas aeruginosa Intramacrophage Survival and Biofilm Formation

43. ERRα promotes breast cancer cell dissemination to bone by increasing RANK expression in primary breast tumors

44. MCM8-and MCM9 Deficiencies Cause Lifelong Increased Hematopoietic DNA Damage Driving p53- Dependent Myeloid Tumors

45. Minimally Invasive versus Open Distal Pancreatectomy for Ductal Adenocarcinoma (DIPLOMA): A Pan-European Propensity Score Matched Study

46. In vitro modulation of multidrug resistance by pregnane steroids and in vivo inhibition of tumour development by 7α-OBz-11α(R)-OTHP-5β-pregnanedione in K562/R7 and H295R cell xenografts

47. Blocking Antibodies Targeting the CD39/CD73 Immunosuppressive Pathway Unleash Immune Responses in Combination Cancer Therapies

48. Enhanced Renewal of Erythroid Progenitors in Myelodysplastic Anemia by Peripheral Serotonin

49. Rapalog combined with CCR4 antagonist improves anticancer vaccines efficacy

50. Strengthening immunomodulatory effects of an anti-tumor monoclonal antibody : study of effects of potentiating combination therapies and analysis of the mechanisms involved

Catalog

Books, media, physical & digital resources